Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Zymeworks Inc ZYME

Healthcare Biotechnology
Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company’s platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT... see more

Current News (NDAQ:ZYME)

Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026

GlobeNewswire 23 hours ago

Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

GlobeNewswire 5 days ago

Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026

GlobeNewswire 6 days ago

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

GlobeNewswire 13 days ago

Zymeworks Appoints Kristin Stafford as Chief Financial Officer

GlobeNewswire April 1, 2026

Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

GlobeNewswire March 30, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire March 24, 2026

Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting

GlobeNewswire March 18, 2026

Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting

GlobeNewswire March 17, 2026
View More News ››

Opinion & Analysis (NDAQ:ZYME)

Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic

Streetwise Reports June 10, 2019
View More Opinion ››

Bullboard Posts (NDAQ:ZYME)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - November 17, 2025

Globe and Mail headline

Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
Possibleidiot01 - November 21, 2024

Zymeworks Inc. (NASDAQ:ZYME): Advancing a Diverse Pipeline o

http://beyondspx.com/2024/08/01/zymeworks-inc-nasdaqzyme-advancing-a-diverse-pipeline-of-novel-biotherapeutics/
MikeTester - August 2, 2024

Paradigm - cantechletter.com

Zymeworks gets a target trim from Paradigm Paradigm Capital analyst Scott McAuley lowered his target a notch on biopharma...
Possibleidiot01 - May 16, 2023

As some have noted..

Yesterday's quarterly and yearly results, smashed earnings and revenue estimates.  ZYME is ridiculously undervalued. ...
Gringotts - March 8, 2023

RE:ZYME contiuing it's trend up

And one she goes this morning. Over 8.70 and shows no signs of slowing down.
7Twiggy - November 15, 2022
View more Bullboard ››

North Peak Resources Ltd.

North Peak Resources Ltd.

North Peak Resources Ltd. operates as a gold exploration and development company. The company’s flagship project is the ...
View More »

Podcasts